For your skin
A Korean botanical that calms angry, reactive skin. Especially soothing during flare-ups.
Want the science? Keep reading ↓Mechanism of action
Polyphenol-rich botanical with antioxidant and anti-inflammatory action on irritated skin.
Why we tier this anecdotal
4 cited papers across 3 countries. Most of what's cited here is mechanism-level or in-vitro work. We track this as Anecdotal until controlled clinical trials accumulate.
Layering matrix
Compare with
Cited research
Wang Y et al., A review of the research progress on Artemisia argyi Folium: botany, phytochemistry, pharmacological activities, and clinical application, Naunyn-Schmiedeberg's Archives of Pharmacology 2024;397(10):7473-7500 — comprehensive review of 136 compounds; documented anti-inflammatory, antioxidant, antibacterial topical use in eczema/dermatitis
Hirano A et al. (Kyushu University, Furue lab), Antioxidant Artemisia princeps extract enhances the expression of filaggrin and loricrin via the AHR/OVOL1 pathway, International Journal of Molecular Sciences 2017;18(9):1948 — Japanese-authored mechanism study explaining how APE upregulates barrier proteins via AHR/OVOL1; no human efficacy trial yet
Lee JH et al., Topical Application of Eupatilin Ameliorates Atopic Dermatitis-Like Skin Lesions in NC/Nga Mice, Annals of Dermatology 2017;29(1):61-68 — Korean-authored study showing topical eupatilin (Artemisia flavonoid) reduced atopic-dermatitis-like lesions and inflammatory markers
Han HM et al., Ameliorative effects of Artemisia argyi Folium extract on 2,4-dinitrochlorobenzene-induced atopic dermatitis-like lesions in BALB/c mice, Molecular Medicine Reports 2016;14(4):3206-3214 — Korean-authored study; Artemisia argyi extract suppressed Th2 cytokines and improved AD lesions
Sources: 10 clinical journals and regulatory databases across the US, EU, Korea, Japan, and China. Every entry points to a specific document. See methodology for the full list and what each outcome label means.